Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Headache, Lethargy, Musculoskeletal stiffness, Myalgia
Clinical narrative: Face red/cheeks red; Stiff neck; injection site it was about 2.5" round feeling very warm; lethargic; Had a fever; Bad headache; Swelling spot, about 2 ½ inches around ( upper left arm); A little red ( injection site); feeling achy all over; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Face red/cheeks red), MUSCULOSKELETAL STIFFNESS (Stiff neck), VACCINATION SITE WARMTH (injection site it was about 2.5" round feeling very warm), LETHARGY (lethargic) and PYREXIA (Had a fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939906, 015M20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Previously administered products included for Product used for unknown indication: Flu vaccine on 13-Oct-2021. Past adverse reactions to the above products included No adverse event with Flu vaccine. Concurrent medical conditions included Diabetic, Fibromyalgia, Arthritis, Blood pressure high and Thyroid disorder. Concomitant products included UBIDECARENONE (COQ-10) for Antioxidant therapy, LISINOPRIL and HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCTZ) for Blood pressure, LOVASTATIN for Cholesterol, INSULIN ASPART (NOVOLOG) for Diabetes, TRAMADOL and GABAPENTIN for Fibromyalgia, LORNOXICAM for Pain, TEMAZEPAM for Sleep disorder NOS, LEVOTHYROXINE for Thyroid disorder NOS, MULTIVITAMIN [VITAMINS NOS], CURCUMA LONGA (TURMERIC [CURCUMA LONGA]) and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Nov-2021, the patient experienced ERYTHEMA (Face red/cheeks red), MUSCULOSKELETAL STIFFNESS (Stiff neck), PYREXIA (Had a fever), HEADACHE (Bad headache), VACCINATION SITE SWELLING (Swelling spot, about 2 ½ inches around ( upper left arm)) and VACCINATION SITE ERYTHEMA (A little red ( injection site)). 02-Nov-2021, the patient experienced VACCINATION SITE WARMTH (injection site it was about 2.5" round feeling very warm), LETHARGY (lethargic) and MYALGIA (feeling achy all over). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL 8 HOUR) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Face red/cheeks red), MUSCULOSKELETAL STIFFNESS (Stiff neck), PYREXIA (Had a fever), HEADACHE (Bad headache), VACCINATION SITE SWELLING (Swelling spot, about 2 ½ inches around ( upper left arm)) and VACCINATION SITE ERYTHEMA (A little red ( injection site)) was resolving and VACCINATION SITE WARMTH (injection site it was about 2.5" round feeling very warm), LETHARGY (lethargic) and MYALGIA (feeling achy all over) had resolved.            patient states that she was feeling 75 percent better. She also mentioned that she was scheduled for an allergy shot today (02-Nov-2021), but canceled. She briefly stated she had muscle pain from the first two doses.   This case was linked to MOD-2021-371881 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Nov-2021: Significant follow-up(events added)